NMES for Achilles Tendon Rupture

Status Recruiting

Clinical Trial Summary

The majority of patients suffering an Achilles tendon rupture develop long term functional deficits in the affected leg. The goal of the proposed study is to evaluate a new rehabilitation protocol using Neuromuscular Electrical Stimulation (NMES) for reducing muscle atrophy and improving tendon properties. If proven beneficial, the proposed protocol can be easily adopted and incorporated as part of routine care for Achilles tendon rupture.

Clinical Trial Description

Achilles Tendon Ruptures (ATR) are common and permanently affect the function of the lower leg. Regardless of treatment approach the majority of patients develop long term functional deficits, which include decreased plantar flexion strength, lower heel-rise height, and altered gait patterns. It is believed that tendon lengthening and calf muscle atrophy, which develop during the first few weeks of recovery, are major factors contributing to these functional deficits. The initial development of atrophy is likely caused by reduced loading and muscle activity of the affected leg. However, long-term atrophy may be related to tendon elongation. On the other hand, tendon elongation initially rises during the first few weeks of unloading and slowly reduces, but not completely, when loading is resumed. However, atrophied calf muscles may not provide sufficient loading for optimal tendon recovery. Therefore, there seems to be vicious spiral between tendon elongation and muscle atrophy. The objective of this study is to develop a neuromuscular electrical stimulation (NMES) rehabilitation protocol for Achilles tendon ruptures. Our preliminary data has shown that force applied to the tendon can be modulated using electrical intensity and pad placement. Therefore, NMES can produce significant contraction in the calf muscles and induce controllable, low-magnitude, cyclic loading to the tendon; which cannot be achieved with voluntary muscle contractions. This approach can potentially overcome limitations of the current rehabilitation protocols. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04727047
Study type	Interventional
Source	Penn State University
Contact	Daniel Cortes
Phone	814-863-3103
Email	dhc13@psu.edu
Status	Recruiting
Phase	N/A
Start date	February 15, 2023
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00537784` - Platelet Concentrate in Achilles Tendon Repair	N/A
Recruiting	`NCT04663542` - The Efficacy of Different Immobilization Times After Achilles Tendon Rupture Surgery	N/A
Withdrawn	`NCT04492059` - Use of Blood Flow Restriction Therapy in Perioperative Rehabilitation Following Achilles Tendon Rupture	N/A
Recruiting	`NCT03259204` - Swedish Multicenter Trial of Outpatient Prevention of Leg Clots	N/A
Completed	`NCT02805751` - Early Controlled Loading on Conservative Treated Achilles Tendon Ruptures	N/A
Completed	`NCT00489749` - A Study Comparing Protected Early Weightbearing Versus Non-Weightbearing After Surgery for Achilles Tendon Rupture	N/A
Active, not recruiting	`NCT03525964` - Individualized Treatment of Acute Achilles Tendon Rupture	N/A
Completed	`NCT02018224` - Achilles Tendon Rupture, Comparison Two Different Operative Techniques. Prospective Randomized Controlled Trial. 14 Years Follow-up.	N/A
Completed	`NCT04121377` - Feasibility of an Early Progressive Strength Exercise Programme for Acute Achilles Tendon Rupture	N/A
Active, not recruiting	`NCT02318472` - Early Mobilization After Achilles Tendon Rupture	N/A
Terminated	`NCT01237613` - Prospective Study on Artelon® Tissue Reinforcement in Repair of Chronic Ruptures and Re-ruptures of the Achilles Tendon	N/A
Recruiting	`NCT06254794` - Effect of BFR Rehab After Achilles Tendon Rupture	N/A
Recruiting	`NCT06009978` - Effect of Additional Treatment With NMES After Achilles Tendon Rupture	N/A
Enrolling by invitation	`NCT05614908` - Outcome After Conservatively Treated Achilles Tendon Rupture
Completed	`NCT03931486` - Detection of Bacterial DNA and Collagen Metabolism in Acutely Ruptured Achilles Tendons
Recruiting	`NCT05683080` - Impact of Achilles Tendon Rupture on the Achilles Tendon and Calf Muscles
Recruiting	`NCT05717270` - Two-layer Suturing of Achilles Tendon Ruptures
Completed	`NCT04263493` - Delayed Loading Following Repair of a Ruptured Achilles Tendon	N/A
Not yet recruiting	`NCT05676632` - Impact of Achilles Tendon Ruptures: Cross-Sectional Analysis
Recruiting	`NCT04912154` - The Efficacy of Different Rehabilitation Protocols After Achilles Tendon Rupture Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.